People News

Share this article:

Marketing research firm IMS Health has announced the election of Bradley Sheares to its board of directors. Shears was most recently CEO of Reliant Pharmaceuticals. Prior to Reliant, Sheares was president of Merck's US human health division.

 

ANI Pharmaceuticals, a specialty generic pharmaceuticals manufacturer, has announced the appointment of Arthur Przbyl as CEO. Przybyl, previously president and CEO of Akorn pharmaceuticals, will also join ANI's board of directors. Przybyl replaces Tom Anderson, ANI's founding CEO, who is leaving to pursue other opportunities.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.